A cost analysis of bone morphogenetic protein versus autogenous iliac crest bone graft in single-level anterior lumbar fusion. Academic Article uri icon

Overview

abstract

  • An economic model was developed to compare costs of stand-alone anterior lumbar interbody fusion with recombinant human bone morphogenetic protein 2 on an absorbable collagen sponge versus autogenous iliac crest bone graft in a tapered cylindrical cage or a threaded cortical bone dowel. The economic model was developed from clinical trial data, peer-reviewed literature, and clinical expert opinion. The upfront price of bone morphogenetic protein (3380 dollars) is likely to be offset to a significant extent by reductions in the use of other medical resources, particularly if costs incurred during the 2 year period following the index hospitalization are taken into account.

publication date

  • October 1, 2003

Research

keywords

  • Bone Morphogenetic Proteins
  • Bone Substitutes
  • Bone Transplantation
  • Lumbar Vertebrae
  • Spinal Fusion
  • Transforming Growth Factor beta

Identity

Scopus Document Identifier

  • 0142217448

Digital Object Identifier (DOI)

  • 10.3928/0147-7447-20031001-12

PubMed ID

  • 14577525

Additional Document Info

volume

  • 26

issue

  • 10